Galecto Inc
NASDAQ:GLTO
Galecto Inc
Interest Income Expense
Galecto Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Interest Income Expense
$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Interest Income Expense
kr1.4B
|
CAGR 3-Years
90%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Interest Income Expense
kr18.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Interest Income Expense
-€132.1m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Interest Income Expense
kr80.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Bioporto A/S
CSE:BIOPOR
|
Interest Income Expense
kr36k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Galecto Inc's Interest Income Expense?
Interest Income Expense
1.5m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Interest Income Expense amounts to 1.5m USD.